Research paperThree-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis
Introduction
In previous work we demonstrated that IgE might be more effective than IgG for the immunotherapy of solid tumours (Gould et al., 1999, Karagiannis et al., 2003). In the course of this work we sought to understand the mechanisms by which IgE effector cells mediate the killing of tumour cells. We employed a monoclonal antibody (MOv18), directed against an ovarian tumour-specific-antigen, folate binding protein (FBP), monocytes as effector cells and the ovarian tumour cell line, IGROV1, which expresses FBP, as target cells (Benard et al., 1985, Campbell et al., 1991, Coney et al., 1991, Tomassetti et al., 1993, Toffoli et al., 1997).
IgE has two cell-bound receptors, the high-affinity receptor, FcεRI, and the low-affinity receptor, CD23 (Gould et al., 2003). The former is homologous to IgG receptors, which mediate antibody-dependent cellular cytotoxicity (ADCC) of tumour cells (Ravetch and Kinet, 1991, Clynes et al., 1998, Clynes et al., 2000, Dyall et al., 1999, Carter, 2006). The low-affinity IgE receptor, CD23, is a member of the C-type lectin superfamily, and has no counterpart among IgG receptors (Gould et al., 2003). CD23, expressed in monocytes, mediates the phagocytosis of hapten-coated red cells (Yokota et al., 1992). We have shown for the first time, by fluorescence microscopy, that IgE receptors on monocytes can also mediate phagocytosis of tumour cells (Karagiannis et al., 2003). We therefore sought to develop an assay to separately quantify IgE antibody monocyte-mediated tumour cell killing by cytotoxicity (ADCC) and phagocytosis (ADCP). Here, we describe a new three-colour cytometric assay that achieves this purpose.
Standard cytotoxicity (ADCC) assays, such as Chromium-51 (51Cr) release (Brunner et al., 1968) and the lactate dehydrogenase (LDH) release (Korzeniewski and Callewaert, 1983), rely on the loss of membrane integrity, associated with cell death, to release an intracellular substance (in some cases, pre-loaded) into the medium, where it can be measured. In the event of phagocytosis, however, these markers are instead released into phagocytes, where they go undetected. The three-colour flow cytometric assay we describe overcomes this problem. It employs three fluorophores to quantify phagocytosis in addition to cytotoxicity. It is based on the same principle as the fluorocytometric (FCM) assay described by Derby et al. (2001), in which the third fluorophore gives information about the mechanism of cytotoxicity, distinguishing the contributions of lytic granule- and Fas Ligand/TNF-mediated apoptosis.
The assay we describe involves labelling of tumour cells with CFSE (Carboxy-fluorescein diacetate, succinimidyl ester), a fluorescent dye normally used to monitor cell proliferation, prior to incubation of antibody with the tumour and effector cells. Following incubation, effector cells are distinguished by Phycoerythrin (PE) labelling of an antigen absent on target cells. Dead cells are labelled with Propidium Iodide (PI). Cell death is then assessed by flow cytometry, whereby five populations can be clearly distinguished: live targets (CFSE+, PE−, PI−), dead targets (CFSE+, PI−, PI+), live effectors (CFSE−, PE+, PI−), dead effectors (CFSE−, PE+, PI+) and phagocytosed target cells (CFSE+, PE+, PI−). The principle of this assay is shown schematically in Fig. 1. We have applied this assay to determine the contribution of cytotoxicity and phagocytosis to MOv18 IgE antibody killing of IGROV1 ovarian tumour target cells by monocytic effector cells, including cells of the U937 cell line and primary peripheral blood monocytes.
Section snippets
Antibodies and reagents
Chimeric antibodies MOv18 IgE against the FBP and NIP IgE specific for the hapten 4-hydroxy-3-nitro-phenacetyl (NIP) were prepared as before (Gould et al., 1999, Neuberger et al., 1985). We used anti-CD89-PE (BD Biosciences, Oxford, UK) and PE-conjugated mouse IgG isotype-matched control antibody (Dako, Glostrup, Denmark). Propidium Iodide (PI), CFSE dye, tissue culture media, and reagents were from Invitrogen (Paisley, UK). Flow cytometric evaluations of fixed (dead) cells were performed using
Flow cytometric ADCC and ADCP assay set up
Voltage and compensation adjustments were made using a series of control tubes performed for each effector or target cell population (Fig. 3). These included live unstained effectors, live PE+ effectors, live CD89-PE-, and PI-stained effectors (Fig. 3A). IGROV1 target cell population controls included live CFSE+ and live CFSE+ with and without CD89-PE, live CFSE+ and PI-stained, or killed (fixed and permeabilised) CFSE+ and PI-stained targets (Fig. 3B).
Calculation of ADCC and ADCP
Twenty thousand events were acquired from
Discussion
We describe here a new flow cytometric method for mechanistic studies of antibody-dependent cell-mediated tumour cell killing, applied to a realistic system. This assay allows the measurement of ADCP, ADCC and total cell killing. IGROV1 tumour target cells are pre-labelled with the green fluorescent dye, CFSE. The CFSE+ target cells are incubated with human U937 or primary monocytic effector cells and anti-FBP MOv18 IgE for tumour cell killing. The monocytes are labelled with PE and dead cells
Acknowledgements
This study was supported by the King's College London Medical School, a Marie-Curie Fellowship and the Association for International Cancer Research, United Kingdom. We are grateful to Dr. Natalie McCloskey and Dr. James Hunt for providing technical expertise and advice, Ms. Kate Kirwan for expert assistance with the figures and Prof. Jean-Pierre Kinet, Dr. Marie-Hélène Jouvin, and Dr. Silvana Canevari for the generous provision of materials and advice.
References (26)
- et al.
Three-color flow cytometric assay for the study of the mechanisms of cell-mediated cytotoxicity
Immunol. Lett.
(2001) - et al.
An enzyme-release assay for natural cytotoxicity
J. Immunol. Methods
(1983) - et al.
Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide
J. Immunol. Methods
(2001) - et al.
A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells
J. Immunol. Methods
(1990) - et al.
Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1
FEBS Lett.
(1993) - et al.
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice
Cancer Res.
(1985) - et al.
Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs
Immunology
(1968) - et al.
Folate binding protein is a marker for ovarian cancer
Cancer Res.
(1991) Potent antibody therapeutics by design
Nat. Rev. Immunol.
(2006)- et al.
Fc receptors are required in passive and active immunity to melanoma
Proc. Natl. Acad. Sci. U. S. A.
(1998)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Nat. Med.
Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein
Cancer Res.
Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor
Eur. J. Immunol.
Cited by (42)
Protocol to drive human monocyte-to-macrophage polarization in vitro using tumor conditioned media
2022, STAR ProtocolsCitation Excerpt :Note: This step investigates the functional behaviour of macrophages with regards to their ability to elicit tumor-cell killing. The assay was adapted from Bracher et al. (2007) and was optimized according to experimental needs. Trypsinize and count melanoma target cells (A375M2, WM88), and label with CFSE (BioLegend) using the CFSE cell division tracker following manufacturer’s instructions (https://www.biolegend.com/de-de/products/cfse-cell-division-tracker-kit-9396).
IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states
2019, EBioMedicineCitation Excerpt :40 cycles of RT-qPCR were performed. ADCC/ADCP assays were performed using a protocol adjusted from a previously-described method [14]. Briefly, target tumour cells were labelled with Carboxyfluorescein succinimidyl ester (CFSE) the day before performing the assay.
AllergoOncology: Generating a canine anticancer IgE against the epidermal growth factor receptor
2018, Journal of Allergy and Clinical ImmunologyMechanism of action of therapeutic monoclonal antibodies: Promises and pitfalls of in vitro and in vivo assays
2012, Archives of Biochemistry and BiophysicsCitation Excerpt :Several means are available to obviate these problems, for example by quenching the fluorescence of bound but not ingested targets. Alternatively, bound but non phagocytosed targets may be labelled with a third fluorescent marker to distinguish between binding and phagocytosis [46]. Finally there are specific dyes which become fluorescent only upon reaching the acidic environment of lysosomes and therefore mark only phagocytosed targets (Fig. 2).